Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 4;9(8):e0003988.
doi: 10.1371/journal.pntd.0003988. eCollection 2015.

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws

Affiliations

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws

Michael Marks et al. PLoS Negl Trop Dis. .

Abstract

Background: Community mass treatment with 30 mg/kg azithromycin is central to the new WHO strategy for eradicating yaws. Both yaws and trachoma--which is earmarked for elimination by 2020 using a strategy that includes mass treatment with 20 mg/kg azithromycin--are endemic in the Pacific, raising the possibility of an integrated approach to disease control. Community mass treatment with azithromycin for trachoma elimination was conducted in the Solomon Islands in 2014.

Methods: We conducted a study to assess the impact of mass treatment with 20 mg/kg azithromycin on yaws. We examined children aged 5-14 years and took blood and lesion samples for yaws diagnosis.

Results: We recruited 897 children, 6 months after mass treatment. There were no cases of active yaws. Serological evidence of current infection was found in 3.6% (95% CI= 2.5-5.0%). This differed significantly between individuals who had and had not received azithromycin (2.8% vs 6.5%, p=0.015); the prevalence of positive serology in 5-14 year-olds had been 21.7% (95% CI=14.6%-30.9%) 6 months prior to mass treatment. Not receiving azithromycin was associated with an odds of 3.9 for infection (p=0.001). National figures showed a 57% reduction in reported cases of yaws following mass treatment.

Discussion: Following a single round of treatment we did not identify any cases of active yaws in a previously endemic population. We found a significant reduction in latent infection. Our data support expansion of the WHO eradication strategy and suggest an integrated approach to the control of yaws and trachoma in the Pacific may be viable.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Prevalence of dual sero-positivity in individuals who did and did not receive treatment with azithromycin.
Fig 2
Fig 2. Yaws clinical case reporting in Western Province, 2011–2014.
The rainy season is indicated in blue and the dry season in yellow. In the pre-mass treatment period there is evidence of seasonal variation in the incidence of yaws, which is well recognized. Following mass treatment there was a profound drop in the number of cases reported.

References

    1. Marks M, Mitjà O, Solomon AW, Asiedu KB, Mabey DC. Yaws. Br. Med. Bull. 2015; 113:91–100. 10.1093/bmb/ldu037 - DOI - PMC - PubMed
    1. Marks M, Solomon AW, Mabey DC. Endemic treponemal diseases. Trans. R. Soc. Trop. Med. Hyg. 2014; 108:601–607. 10.1093/trstmh/tru128 - DOI - PMC - PubMed
    1. Perine PL, Hopkins DR, Niemel PLA, St. John R, Causse G, Antal GM. Handbook of endemic treponematoses: yaws, endemic syphilis and pinta. Geneva, Switzerland: World Health Organization, 1984. Available at: http://apps.who.int/iris/handle/10665/37178?locale=en. Accessed 2 May 2013.
    1. Asiedu K, Amouzou B, Dhariwal A, et al. Yaws eradication: past efforts and future perspectives. Bull. World Health Organ. 2008; 86:499–499A. - PMC - PubMed
    1. Mitjà O, Hays R, Ipai A, et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 2012; 379:342–347. 10.1016/S0140-6736(11)61624-3 - DOI - PubMed

Publication types